$USAC

USA Compression (NYSE: USAC) shows pro forma impact of $912M J-W Power deal

USA Compression Partners (NYSE: USAC) filed an amended report detailing the pro forma impact of its $912 million J-W Power acquisition, which closed in January 2026. The acquisition, valued at approximately $911.6 million (half cash, half equity), is expected to increase net income attributable to common unitholders to $127.2 million for 2025 on a pro forma basis, with basic earnings per unit rising to $0.92. The report includes J-W Energy's audited 2025 financial statements and outlines how purchase accounting adjustments, such as increased property, equipment, goodwill, and long-term debt, affect USA Compression's financial outlook.

Original reporting
Published Mar 31, 2026, 5:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 31, 2026, 5:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
USA Compression (NYSE: USAC) shows pro forma impact of $912M J-W Power deal — source image
Decision brief

The 30-second read

$USACBullishMed
01

Why it matters

The $912 million acquisition of J-W Power enhances USAC's revenue streams and asset valuation, likely leading to improved investor confidence and stock performance.

02

Market read

The acquisition signifies a strategic move within the energy transportation sector, with potential ripple effects on related companies and industry sentiment.

03

What to watch

Potential integration challenges and market saturation could temper expected gains; macroeconomic factors such as interest rate changes may influence performance.

Timing: Immediate to short-term (next 1-3 months)

Background

USA Compression Partners (USAC) is a key player in energy transportation infrastructure, with recent strategic acquisitions aimed at expanding its asset base and market share.

Company-level read

Ticker impact

$USACBullishHigh confidence
Context

High relevance due to significant acquisition impact and financial outlook revision.

Expected impact

Moderate upward movement expected in USAC stock price over the next 1-3 months.

Evidence & confidence

The pro forma financial improvements and increased net income suggest a solid growth trajectory, supported by the recent acquisition. The inclusion of audited financial statements adds credibility to the projected benefits.

Market effects

Potential positive sentiment in energy transportation and infrastructure sectors due to consolidation activity.

Limited regional impact; primarily affects USAC and related entities.

Low; specific to USAC and its immediate industry.

Counterpoint

Some analysts may view the increased debt and goodwill on USAC's balance sheet as potential risks, possibly leading to overvaluation.

Key entities

  • USA Compression Partners

    A provider of natural gas compression services and infrastructure.

  • J-W Power

    A provider of energy and power solutions, recently acquired by USAC.

Related articles

$USACMed

United States Antimony Corporation Q2 2026 Earnings Call Summary

United States Antimony Corp. reported Q2 2026 revenue down 25% year over year, driven mainly by a 52% fall in realized antimony prices. The company is building $21.6M inventory for its sole-source DLA contract and raised zeolite segment revenue 110%. Full-year 2026 revenue guidance was cut to $60-$75M due to lower pricing; it has $62.2M cash plus a $43.2M Larvotto equity stake.

$USACMed

USA Compression Partners Q2 Earnings Call Highlights

USA Compression Partners (NYSE:USAC) reported Q2 metrics including 4.95 million total fleet horsepower, 92% utilization, and average revenue per revenue-generating horsepower per month of $22.84. Adjusted gross margin was 63.5% and leverage was 3.72x. The firm reaffirmed 2026 outlook for adjusted EBITDA $770m-$800m and distributable cash flow $480m-$510m, plus capex guidance.

$USACMed

USA Compression Partners, LP (USAC): Results of Operations and Financial Condition

USA Compression Partners, LP (USAC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release USA Compression Partners, LP 8115 Preston Road, Suite 700 Dallas, Texas 75225 usacompression.com USA Compression Partners Reports Second-Quarter 2026 Results DALLAS, Texas, August 4, 2026 — USA Compression Partners, LP (NYSE: USAC) (“USA Compression” or

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.